Kongressberichte & Archiv

Annual Meeting of the American Society of Clinical Oncology 2019

Breast Cancer News Interviews

Metastasierter HER2-positiver Brustkrebs

Renate Haidinger, Brustkrebs Deutschland e.V im Interview mit:

Volkmar Müller, Hamburg: Ml:etastaserter HER2-positiver Brustkrebs:

News

TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial

31-01-2020 22:56
The combination of TAS-102 plus bevacizumab could be a new treatment option for patients with refractory metastatic colorectal cancer and could be a practice-changing development (cited in the Lancet Oncology)
Weiterlesen ...
TRENDING NOW ON JAMA ONCOLOGY:

09-01-2020 17:50
Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Breast Cancer That Progressed on Endocrine Therapy
Establishing a SAKK Working Group for Cellular Therapies

19-12-2019 22:08
PRESS RELEASE
Date Bern, December 12, 2019
Weiterlesen ...